Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of simplified regional citrate anticoagulation during hemodialysis
NL-OMON41845Not yet recruiting
- Sponsor
- Albert Schweitzer Hospital
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of trisodium citrate, low molecular weight heparin calcium, calcium chloride and magnesium chloride in chronic kidney disease (CKD) (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoint: Systemic anticoagulation assessed by thromboelastography. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
trisodium citratelow molecular weight heparin calciumcalcium chloridemagnesium chloride
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON41845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41845.